← Back to Search

CAR T-cell Therapy

Web Application for Lymphoma

N/A
Waitlist Available
Led By Rahul Banerjee, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights

Study Summary

This trial tests whether the CC web app can help patients better understand and manage CAR-T therapy.

Eligible Conditions
  • Lymphoma
  • Leukemia
  • Multiple Myeloma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of participants agreeing or strongly agreeing with helpfulness of CC web application.
Percentage of participants who access all four CC web application modules at least once
Secondary outcome measures
Number of times an Electronic immune effector-cell associated encephalopathy assessment (eICE) is reported
Number of times that temperature >= 38. degrees Celsius (°C) is reported

Trial Design

1Treatment groups
Experimental Treatment
Group I: Companion for CAR-T Web Application (CC)Experimental Treatment1 Intervention
Enrolled participants and caregivers will receive access to the CC web application during the participants Chimeric Antigen Receptor T-cell (CAR-T) therapy. Key components include (1) educational videos and materials, (2) appointment calendars and 'Appointment Companion' features to prepare for clinical appointments, and (3) tools to assist with vital sign and neurological monitoring at home.

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,503 Previous Clinical Trials
15,236,655 Total Patients Enrolled
18 Trials studying Lymphoma
234 Patients Enrolled for Lymphoma
Rahul Banerjee, MDPrincipal InvestigatorUniversity of California, San Francisco
4 Previous Clinical Trials
227 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research have any open positions for participants?

"The information displayed on clinicaltrials.gov affirms that this research endeavour is not currently recruiting participants at present, despite being initially published on January 1st 2023 and last updated October 4th 2022. Nevertheless, there are 3 499 other trials actively seeking patients right now."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Companion for CAR-T Web App During Chimeric Antigen Receptor T-cell Therapy
2023. "Companion for CAR-T Web App During Chimeric Antigen Receptor T-cell Therapy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05362331.
~0 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top